Boai NKY Pharmaceuticals Ltd (300109) — Cash Flow Reinvestment Rate
Boai NKY Pharmaceuticals Ltd (300109) has a Cash Flow Reinvestment Rate of 0.30x as of September 2025, reinvesting CN¥41.41 Million (capex CN¥41.41 Million ) from operating cash flow of CN¥139.46 Million. See free cash flow generation of Boai NKY Pharmaceuticals Ltd to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Boai NKY Pharmaceuticals Ltd Cash Flow Reinvestment Rate (2007–2025)
Historical reinvestment intensity for Boai NKY Pharmaceuticals Ltd across 18 annual periods. For the full cash flow conversion analysis, see 300109 cash generation efficiency.
Annual Cash Flow Reinvestment Rate for Boai NKY Pharmaceuticals Ltd (2007–2025)
Year-by-year capital reinvestment analysis for Boai NKY Pharmaceuticals Ltd. See Boai NKY Pharmaceuticals Ltd financial flexibility index to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.78x | CN¥265.14 Million | CN¥338.11 Million | CN¥220.42 Million | ▼ -42.6% |
| 2024 | 1.37x | CN¥349.68 Million | CN¥256.03 Million | CN¥274.68 Million | ▼ -27.7% |
| 2023 | 1.89x | CN¥922.52 Million | CN¥488.25 Million | CN¥377.88 Million | ▲ +70.8% |
| 2022 | 1.11x | CN¥278.44 Million | CN¥251.77 Million | CN¥266.00 Million | ▼ -89.6% |
| 2021 | 10.68x | CN¥463.85 Million | CN¥43.44 Million | CN¥228.32 Million | ▲ +2487.3% |
| 2020 | 0.41x | CN¥110.14 Million | CN¥266.87 Million | CN¥99.24 Million | ▼ -85.8% |
| 2019 | 2.91x | CN¥231.96 Million | CN¥79.64 Million | CN¥142.35 Million | ▼ -60.7% |
| 2018 | 7.41x | CN¥361.81 Million | CN¥48.81 Million | CN¥124.37 Million | ▼ -11.8% |
| 2017 | 8.40x | CN¥397.23 Million | CN¥47.28 Million | CN¥129.23 Million | ▲ +509.6% |
| 2016 | 1.38x | CN¥157.33 Million | CN¥114.14 Million | CN¥48.47 Million | ▲ +118.3% |
| 2015 | 0.63x | CN¥40.48 Million | CN¥64.12 Million | CN¥40.48 Million | ▼ -37.6% |
| 2014 | 1.01x | CN¥47.11 Million | CN¥46.60 Million | CN¥47.11 Million | ▼ -34.0% |
| 2013 | 1.53x | CN¥35.47 Million | CN¥23.17 Million | CN¥35.47 Million | ▼ -65.3% |
| 2012 | 4.41x | CN¥90.96 Million | CN¥20.65 Million | CN¥90.96 Million | ▼ -83.4% |
| 2011 | 26.46x | CN¥104.29 Million | CN¥3.94 Million | CN¥104.29 Million | ▲ +1144.2% |
| 2010 | 2.13x | CN¥21.38 Million | CN¥10.05 Million | CN¥21.38 Million | ▲ +140.5% |
| 2009 | 0.88x | CN¥25.27 Million | CN¥28.57 Million | CN¥25.27 Million | ▲ +77.3% |
| 2007 | 0.50x | CN¥4.77 Million | CN¥9.56 Million | CN¥4.77 Million | — |